Skip to main content
CDC Website

HIV and AIDS

HIV Stops With Me

Image:
HIV Stops With Me Logo
HIV Stops With Me
Better World Advertising
Since its inception in 2000, HIV Stops With Me is a multifaceted, national social-marketing campaign that aims to prevent the spread of HIV while also reducing the stigma associated with the disease. The campaign features real HIV positive people talking about real issues. The campaign focuses on...

Status Sexy

Image:
Status Sexy Logo
Status Sexy
Date Created:
AIDS Partnership Michigan

Status Sexy is a grassroots movement to increase testing and decrease the stigma around HIV for young men. This site is a place for young men to get the facts on HIV and express themselves as the generation that has only known the world with HIV/AIDS as a part of it. No matter the outcome of the...

Tuberculosis and AIDS

This report, for health professionals, government agencies, and organizations, presents information about HIV/AIDS and TB. It provides epidemiological statistics concerning the relationship between HIV/AIDS and TB, including incidence, morbidity rates, and mortality rates. It discusses TB and HIV transmission, how HIV can facilitate the development of active TB, and recommendations for the prevention of TB among HIV-positive persons.

Prisons and AIDS: UNAIDS Point of View

This technical update reviews the incidence and prevalence of HIV in correctional facilities around the world and explains how this morbidity rate impacts the general public. The risk factors for HIV transmission in correctional facilities are reviewed and include drug injection, unprotected sexual relations, tattooing, skin piercing, blood brotherhood rites, lack of education, TB, and overcrowding. Suggestions for preventing the transmission of HIV in correctional settings are presented.

MMWR: Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV - Infected Tuberculosis Patients With Rifampin

This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors interact with rifamycin derivatives, which are used to treat and prevent the mycobacterial infections commonly observed in patients with the HIV. The report provides background information on the management of TB and the three treatment options currently available for these patients.

1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults

This report contains CDC's revised classification system for HIV infection and AIDS among adolescents and adults. The definition replaces the system published by CDC in 1986 and contains the expanded AIDS surveillance case definition. Appendixes include equivalences for CD4+ T-lymphocyte count and percentage of total lymphocytes, conditions included in the 1993 AIDS surveillance case definition, definitive diagnostic methods for diseases indicative of AIDS, and suggested guidelines for presumptive diagnosis of diseases indicative of AIDS.

Preventing Infections From Pets: A Guide for People With HIV Infection

This brochure provides information on the prevention of infections from pets for persons with HIV. Most persons with HIV can keep their pets but they should know the health risks associated with owning a pet or caring for animals. Animals may carry diseases that if passed to a person with HIV can result in diarrhea, brain infections, and skin lesions.

Preventing Needlestick Injuries in Health Care Settings

This report provides guidelines regarding the prevention of needlestick injuries in health care settings. Bloodborne pathogens that may be transmitted during needlestick injuries include HIV, hepatitis B, and hepatitis C. The report identifies activities associated with needlestick injuries and describes Occupational Safety and Health Administration (OSHA) and Food and Drug Administration (FDA) guidelines for the prevention of such injuries in the workplace.

HIV-Related Opportunistic Diseases

This report provides information about opportunistic infections (OIs) among persons with HIV. It discusses the causes, effects, and treatments available and includes a comparison of costs of treatment and prophylaxis for the most common OIs. It provides recommendations to improve healthcare and prevent OIs among HIV-positive persons.

MMWR: Notice to Readers: Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons

This report in the form of a notice to readers states that CDC in conjunction with the American Thoracic Society expects to issue new guidelines on screening and preventive therapy for TB that will include a recommendation on the use of the two-month regimen of daily rifampin and pyrazinamide (2RZ) as an alternative to 12-month isoniazid for prevention of TB in HIV-negative persons for whom preventive therapy is indicated. A comparative trial of the 2RZ regimen in HIV-negative persons has not been conducted.